Cleft lip and palate (CLP) are complex congenital anomalies with multifactorial etiology and significant genetic heterogeneity. This study aimed to elucidate the genetic basis of nonsyndromic CLP in an Indian family, wherein phenotypically normal parents had three affected offspring, including monozygotic twins, all presenting with bilateral complete CLP. Whole exome sequencing (WES) identified a compound heterozygous haplotype in the TTN gene shared by all affected siblings. The paternal haplotype comprised variants c.96140C>T (p.Thr32047Met), c.77412C>G (p.Phe25804Leu), c.2605A>T (p.Thr869Ser), and c.18663A>C (p.Glu6221Asp), while the maternal haplotype included variants c.107779G>A (p.Glu35927Lys), c.103147G>C (p.Glu34383Gln), c.63907G>A (p.Val21303Met), and c.26863A>G (p.Ile8955Val). In silico analyses predicted these variants to have deleterious effects on protein structure and function, consistent with a recessive mode of inheritance. Although TTN is primarily known for its role in muscle structure and function, emerging evidence implicates its involvement in craniofacial development. This study expands the phenotypic spectrum of TTN-associated disorders and suggests a novel role for TTN in nonsyndromic CLP. These findings underscore the importance of comprehensive genomic analyses in unraveling the molecular mechanisms underlying complex congenital anomalies.

The authors have declared no competing interest.

This study was funded by IoE, BHU

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committee of Institute of Science, Banaras Hindu University, Varanasi gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript.